Sinovac Biotech Ltd

SVQ

Company Profile

  • Business description

    Sinovac Biotech Ltd is a fully integrated China-based biopharmaceutical company focused on the research, development, manufacturing and commercialization of vaccines for the prevention of human infectious diseases, including certain diseases with unmet medical needs. It has developed a comprehensive vaccine portfolio covering hepatitis A, hepatitis B, hand, foot and mouth disease ("HFMD") caused by enterovirus 71 ("EV71"), seasonal and pandemic influenza, COVID-19, pneumococcal disease, poliomyelitis, mumps, varicella, rabies and tetanus. The Company operates exclusively in the research, development, manufacture, and commercialization of vaccines sector. The Company's business is considered as operating in one segment. It has presence in Chinese Mainland, and Outside Chinese Mainland.

  • Contact

    No.39, Shangdi Xi Road
    Haidan District
    Beijing100085
    CHN

    T: +86 1082799800

    E: [email protected]

    http://www.sinovac.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    2,602

Stocks News & Analysis

stocks

Nvidia earns upgrade as AI buildouts accelerate

Demand for AI infrastructure shows no signs of slowing.
stocks

ASX supermarket share outperforms

Supermarket turnaround drives earnings higher.
stocks

Weekly earnings wrap: FMG, WDS, COL and more

A closer look at the final major results from August reporting season.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,294.3032.900.36%
CAC 408,401.1881.310.98%
DAX 4026,569.99202.750.77%
Dow JONES (US)53,559.999.45-0.02%
FTSE 10010,824.2631.720.29%
HKSE25,584.7919.050.07%
NASDAQ26,402.42138.93-0.52%
Nikkei 22566,405.56273.590.41%
NZX 50 Index13,768.18111.87-0.81%
S&P 5007,711.7619.23-0.25%
S&P/ASX 2009,092.3041.000.45%
SSE Composite Index3,952.184.39-0.11%

Market Movers